• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[全血γ-干扰素释放试验增强版与全血γ-干扰素释放试验在肺结核诊断中的比较]

[Comparison of QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In Tube in the diagnosis of pulmonary tuberculosis].

作者信息

Wang X Y, Su B Y, Chen Z Y, Kuang H B, Guan P, Cao Z Z, Tan Y J

机构信息

Graduate School, Guangzhou Medical University, Guangzhou 511436, China.

Department of Pathogenic Laboratory, Guangzhou Chest Hospital, Guangzhou 510095, China.

出版信息

Zhonghua Jie He He Hu Xi Za Zhi. 2022 May 12;45(5):445-452. doi: 10.3760/cma.j.cn112147-20220206-00095.

DOI:10.3760/cma.j.cn112147-20220206-00095
PMID:35527459
Abstract

To compare the screening value of QuantiFERON-TB Gold Plus (QFT-Plus) and QuantiFERON®-TB Gold in tube (QFT-GIT) in the auxiliary diagnosis of pulmonary tuberculosis (TB). A screening test was performed. Patients who were hospitalized in Guangzhou Chest Hospital and underwent QFT-GIT testing from October to December 2020 were prospectively included as research subjects, QFT-Plus testing was added. And the basic information, clinical manifestations, laboratory test results, imaging examinations and other data of these patients were collected. A total of 207 patients were included and divided into tuberculosis group and non-tuberculosis group according to these data. There were 124 cases in the tuberculosis group (94 confirmed patients and 30 clinically diagnosed patients), including 90 males and 34 females, aged 18-93 years, with a median age of 57 (38, 67) years. The non-tuberculosis group included 83 patients (16 patients with non-tuberculous and 67 patients with other lung diseases), including 49 males and 34 females, with a median age of 60 (51, 68) years. The confirmed patients were subdivided into three grades of low, medium and high (MTB) bacterial load, and three grades of mild, moderate and severe pulmonary tuberculosis. The results of QFT-Plus and QFT-GIT were compared, and the levels of IFN-γ in different antigen tubes were compared. Differences between different groups were compared using Mann-Whitney test and Kruskal-Wallis test. The QFT-Plus showed a high degree of agreement with the QFT-GIT (=0.786, 95%: 0.740-0.832), while the main discordant result was QFT-GIT negative/QFT-Plus positive, accounting for 15/17. The sensitivity of QFT-GIT was 80.7%(95%: 0.706-0.880), the specificity was 76.3%(95%: 0.649-0.850), the positive predictive value was 79.8%(95%: 0.697-0.873), and the negative predictive value was 77.3%(95%: 0.659-0.859), repectively. QFT-Plus showed a sensitivity of 84.3%(95%: 0.743-0.910), a specificity of 78.8% (95%: 0.679-0.868), and a positive predictive value of 80.5%(95%: 0.703-0.879), the negative predictive value being 82.9%(95%: 0.721-0.902), slightly improved to that of the QFT-GIT. Also, this study found that there were significant differences in IFN-γ values between different MTB load or disease severity (<0.05). There is a good consistency between the QFT-Plus test and the QFT-GIT test, both of which show good application value in the auxiliary diagnosis of pulmonary tuberculosis. Moreover, because of the addition of tuberculosis-specific CD8 cell antigen, the QFT-Plus test has higher sensitivity, lower uncertainty and more application value. This study also found that the bacterial load and disease severity of patients with pulmonary tuberculosis may have a certain correlation with the measured value of IFN-γ.

摘要

比较全血γ-干扰素释放试验增强版(QFT-Plus)和全血γ-干扰素释放试验(QFT-GIT)在肺结核辅助诊断中的筛查价值。进行了一项筛查试验。前瞻性纳入2020年10月至12月在广州市胸科医院住院并接受QFT-GIT检测的患者作为研究对象,增加QFT-Plus检测。收集这些患者的基本信息、临床表现、实验室检查结果、影像学检查等数据。共纳入207例患者,根据这些数据分为结核组和非结核组。结核组124例(确诊患者94例,临床诊断患者30例),其中男性90例,女性34例,年龄18 - 93岁,中位年龄57(38,67)岁。非结核组包括83例患者(非结核患者16例,其他肺部疾病患者67例),其中男性49例,女性34例,中位年龄60(51,68)岁。确诊患者细分为低、中、高三个等级的结核分枝杆菌(MTB)菌量以及轻、中、重三个等级的肺结核。比较QFT-Plus和QFT-GIT的结果,并比较不同抗原管中IFN-γ水平。采用Mann-Whitney检验和Kruskal-Wallis检验比较不同组间差异。QFT-Plus与QFT-GIT显示出高度一致性(κ=0.786,95%CI:0.740 - 0.832),而主要不一致结果为QFT-GIT阴性/QFT-Plus阳性,占15/17。QFT-GIT的敏感性为80.7%(95%CI:0.706 - 0.880),特异性为76.3%(95%CI:0.649 - 0.850),阳性预测值为79.8%(95%CI:0.697 - 0.873),阴性预测值为77.3%(95%CI:0.659 - 0.859)。QFT-Plus的敏感性为84.3%(95%CI:0.743 - 0.910),特异性为78.8%(95%CI:0.679 - 0.868),阳性预测值为80.5%(95%CI:0.703 - 0.879),阴性预测值为82.9%(95%CI:0.721 - 0.902),较QFT-GIT略有提高。此外,本研究发现不同MTB菌量或疾病严重程度之间的IFN-γ值存在显著差异(P<0.05)。QFT-Plus检测与QFT-GIT检测具有良好的一致性,两者在肺结核辅助诊断中均显示出良好的应用价值。而且,由于添加了结核特异性CD8细胞抗原,QFT-Plus检测具有更高的敏感性、更低的不确定性和更大的应用价值。本研究还发现肺结核患者的菌量和疾病严重程度可能与IFN-γ测量值存在一定相关性。

相似文献

1
[Comparison of QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In Tube in the diagnosis of pulmonary tuberculosis].[全血γ-干扰素释放试验增强版与全血γ-干扰素释放试验在肺结核诊断中的比较]
Zhonghua Jie He He Hu Xi Za Zhi. 2022 May 12;45(5):445-452. doi: 10.3760/cma.j.cn112147-20220206-00095.
2
Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers.比较结核感染 T 细胞斑点酶联免疫法(QuantiFERON-TB Gold Plus)和结核感染 T 细胞酶联免疫法(QuantiFERON-TB Gold In-Tube)在结核病高危人群和医护人员中的应用。
J Clin Microbiol. 2018 Jun 25;56(7). doi: 10.1128/JCM.00614-18. Print 2018 Jul.
3
Comparative Results of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus Assays for Detection of Tuberculosis Infection in Clinical Samples.全血γ-干扰素释放试验和增强版全血γ-干扰素释放试验检测临床样本中结核感染的比较结果
J Clin Microbiol. 2020 Mar 25;58(4). doi: 10.1128/JCM.01854-19.
4
Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation.干扰素释放试验用于活动性结核病的诊断评估(IDEA):试验准确性研究和经济评估。
Health Technol Assess. 2019 May;23(23):1-152. doi: 10.3310/hta23230.
5
Comparison of QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube tests for patients with active and latent tuberculosis: A prospective cohort study.比较活动性和潜伏性结核病患者使用 QuantiFERON-TB Gold Plus 和 QuantiFERON-TB Gold In-Tube 检测的效果:一项前瞻性队列研究。
J Infect Chemother. 2021 Dec;27(12):1694-1699. doi: 10.1016/j.jiac.2021.08.003. Epub 2021 Aug 16.
6
Comparison of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold-Plus in the Diagnosis of Infections in Immunocompromised Patients: a Real-World Study.QuantiFERON-TB Gold In-Tube 与 QuantiFERON-TB Gold-Plus 在免疫抑制患者感染诊断中的比较:一项真实世界研究。
Microbiol Spectr. 2022 Apr 27;10(2):e0187021. doi: 10.1128/spectrum.01870-21. Epub 2022 Mar 2.
7
First evaluation of QuantiFERON-TB Gold Plus performance in contact screening.结核感染 T 细胞检测试剂盒(酶联免疫斑点法)在接触者筛查中的初步评价
Eur Respir J. 2016 Nov;48(5):1411-1419. doi: 10.1183/13993003.00510-2016. Epub 2016 Jul 7.
8
[The evaluation of the utility of QuantiFERON TB-Gold In-Tube; QFT-GIT].[全血γ-干扰素释放试验(QFT-GIT)的应用评估]
Kekkaku. 2014 Sep;89(9):743-55.
9
QuantiFERON-TB Gold PLUS versus QuantiFERON- TB Gold In-Tube test for diagnosing tuberculosis infection.QuantiFERON-TB Gold PLUS 与 QuantiFERON-TB Gold In-Tube 检测在诊断结核感染中的比较。
Korean J Intern Med. 2020 Mar;35(2):383-391. doi: 10.3904/kjim.2019.002. Epub 2019 Dec 26.
10
Variation in interferon-γ production between QFT-Plus and QFT-GIT assays in TB contact investigation.结核接触者调查中QFT-Plus检测与QFT-GIT检测在干扰素-γ产生方面的差异。
Respir Investig. 2019 Nov;57(6):561-565. doi: 10.1016/j.resinv.2019.07.002. Epub 2019 Aug 8.